Latest Insulin Stories
SAN DIEGO, Jan. 23, 2013 /PRNewswire/ -- Celladon Corporation, a biopharmaceutical company focused on the discovery and development of innovative treatments for cardiovascular diseases, announced today that the United States Patent and Trademark Office (USPTO) issued a notice of allowance for U.S. Patent Application No.: 13/145,787 with claims that cover methods for identifying compounds that modulate Sarco/Endoplamic Reticulum Calcium ATPase (SERCA) and methods for identifying...
CALGARY, Alberta, Jan. 22, 2013 /PRNewswire/ -- Fero Industries, Inc. (OTC: FROI), the exclusive producer, marketer & distributor of Sucanon®, an oral type-2 Diabetes treatment, announced today that the company has hired Barry Hall, through his consulting company Carlaris LV Inc., as Interim CFO. Mr. Hall is the former CFO of EarthLink and brings extensive experience in accounting, corporate governance and strategic planning to the company. "Barry's high level of experience is...
PUNE, India, Jan. 15, 2013 /PRNewswire/ -- India's President Pranab Mukherjee and Tripura State Governor Dr. D. Y. Patil, both praised the latest ground breaking diabetes device developed by Rana Arefieg of Global Innovations at a private event held for inauguration of "D.Y. Patil Knowledge City" honoring the Governor of Tripura last month. The 1Clik(TM), an insulin injector, glucose monitor and wireless communications system in one caught the attention of the President who then...
TORONTO, Jan. 15, 2013 /PRNewswire/ -- According to Millennium Research Group (MRG), the global authority on medical technology market intelligence, the continued increase in the prevalence of diabetes, combined with an expansion of insurance coverage as a consequence of healthcare reform, will cause the United States diabetes care device market to grow to nearly $16 billion by 2017. The market segments for continuous glucose monitoring (CGM) devices, insulin pumps and pens will...
ANN ARBOR, Mich., Jan. 14, 2013 /PRNewswire/ -- Hygieia, Inc. today announced receipt of a Notice of Allowance from the U.S. Patent and Trademark Office for core patent claims broadly covering the company's Diabetes Insulin Guidance System (DIGS(TM)) technology. The patent application entitled "System for Optimizing a Patient's Insulin Dosage Regimen" relates to Hygieia's unique methods of automatically adjusting a diabetic patient's insulin dosage as needed to achieve a better...
RARITAN, N.J., Jan. 10, 2013 /PRNewswire/ -- Janssen Research & Development, LLC (Janssen) announced today that the Endocrinologic and Metabolic Drugs Advisory Committee of the U.S. Food and Drug Administration (FDA) voted 10-5 to recommend approval for canagliflozin, proposed trade name INVOKANA(TM), to treat type 2 diabetes in adult patients based on the efficacy and safety results from its comprehensive clinical development program. Canagliflozin is an investigational, oral,...
NEW YORK, Jan. 8, 2013 /PRNewswire/ -- Islet Sciences, Inc., (OTC Bulletin Board: ISLT) a clinical stage company engaged in the research, development and commercialization of therapeutics in the field of diabetes, announced today that it was included in the December 27, 2012 issue of BioWorld Today. A link to the full text of the article is below. "Inclusion in BioWorld is another validation point as this esteemed industry publication recognizes the potential of Islet Sciences,"...
SAN DIEGO, Jan. 8, 2013 /PRNewswire/ -- Tandem Diabetes Care, Inc. ("Tandem") announced today a partnership with JDRF, the leading global organization focused on type 1 diabetes (T1D) research, to develop a first-of-its-kind, dual-chamber infusion pump for the management of diabetes. The partnership agreement is designed to accelerate the development of a next-generation, fully automated artificial pancreas system using therapies in conjunction with insulin. "An ambulatory device...
SOUTH HACKENSACK, N.J., Jan. 8, 2013 /PRNewswire/ -- Naturex, the global leader in natural specialty ingredients, is the creator of Svetol®, the most studied and proven green coffee bean extract for weight loss. By regulating sugar and fat use as a source of energy, this revolutionary ingredient is the only plant extract of decaffeinated green coffee that simultaneously spurs weight loss and improves your body's form (www.svetol.com). Svetol® is a unique green coffee bean...
INDIANAPOLIS and ROLLING MEADOWS, Ill., Jan. 8, 2013 /PRNewswire/ -- For a second year in a row, Lilly Diabetes will donate $100,000 to the Diabetes Scholars Foundation (Foundation) scholarship fund. The contribution will support the Foundation's mission to empower young people with type 1 diabetes to live their lives to the fullest. The Foundation will use the donation to fund the Lilly Diabetes Tomorrow's Leaders Scholarships for students with type 1 diabetes as well as conference...
Latest Insulin Reference Libraries
The pancreas is a digestive and an endocrine organ with both endocrine and exocrine functions. It is about six inches long located in the upper portion of the abdominal cavity. The head of the pancreas lies within the indentation of the duodenum and is connected to it by the pancreatic duct. The uncinate process extends from the head and the neck connects to the body of the pancreas, which lies directly behind the stomach. The tail of the pancreas extends to the left side of the body and is...
Insulin, a hormone, is used to regulate carbohydrate and fat metabolism in the body. Insulin causes cells to take up glucose from the blood and store it as glycogen in the liver and muscle. This hormone stops the body from using fat as an energy source by inhibiting the release of glucagons. Without insulin the body fails to take glucose into the bodies cells and in turns uses fat as an energy source. It also has several other anabolic effects throughout the body. Diabetes mellitus results...
